Skip to Content

Can you carry gonorrhea but test negative?

It is possible to carry gonorrhea but test negative. This can happen for a few reasons:

False negatives

No test is 100% accurate. Gonorrhea tests, like all medical tests, have a chance of giving a false negative result. This means the test may incorrectly show a negative result when you actually do have the infection.

Some key facts about false negative gonorrhea test results:

  • False negatives are more likely to occur with urine tests than swab tests. Urine tests can miss up to 50% of gonorrhea infections, while swab tests are over 95% accurate.
  • Testing too early can cause false negatives. It can take 1-14 days after infection for gonorrhea to be detectable.
  • Proper sample collection is vital. An improper urinary sample or swab can lead to inaccurate test results.
  • Some strains of gonorrhea are harder to detect. The CDC reports there are antibiotic resistant strains that may not be identified by some tests.

So in summary, it is possible to still have gonorrhea even if a test comes back negative, especially if it was a urine test. Retesting should be done if symptoms persist.

Asymptomatic infection

Gonorrhea can also be asymptomatic, meaning it causes no obvious symptoms. Some key facts on asymptomatic gonorrhea:

  • Around 10-15% of men and 40–80% of women with gonorrhea have no symptoms.
  • Asymptomatic infections are more common in the throat and rectum.
  • Typical symptoms like discharge, burning urination, abdominal pain may be absent.
  • Without symptoms, many people don’t get tested and unknowingly transmit the infection.

So it’s entirely possible to have a gonorrhea infection, but have a negative test result because you didn’t realize you needed testing.

Window period after treatment

After taking antibiotics to treat gonorrhea, it is still possible to test positive for up to 3 weeks. This does not mean the antibiotics failed – it simply means there is still genetic material from dead gonorrhea bacteria in your system.

Key points about testing after treatment:

  • The CDC recommends waiting 3-4 weeks after finishing antibiotics before getting retested.
  • Nucleic acid amplification tests (NAAT) can detect gonorrhea genetic material even from dead bacteria.
  • It takes time for your body to clear this material, so testing too soon may give a misleading positive result.
  • If symptoms persist or return, retesting should be done ASAP instead of waiting.

So in the window after antibiotic treatment, it’s common to still test positive on highly sensitive NAAT tests. But this doesn’t mean the antibiotics failed. Retesting after 3-4 weeks provides a more accurate result.

Co-infections with chlamydia

Around 40-60% of people with gonorrhea are also infected with chlamydia. Some key facts:

  • Chlamydia and gonorrhea often infect people at the same time due to similar transmission.
  • In women, chlamydia and gonorrhea cause similar symptoms like discharge and pelvic pain.
  • Many gonorrhea tests also detect chlamydia, but not vice versa.
  • So if chlamydia, but not gonorrhea, is detected, symptoms may persist leading to retesting.

In summary, concurrent chlamydia infection explains some situations where people test negative for gonorrhea but still have symptoms that lead to retesting.

Cervical infection in women

For women, false negatives on gonorrhea testing are more common if cervical infections are missed.

  • Gonorrhea commonly infects the cervix (opening of the uterus).
  • Urine testing misses cervical infections around 40% of the time.
  • Vaginal swabs also aren’t as accurate as cervical swabs.
  • Cervical swabs during pelvic exams lead to the most accurate gonorrhea test results in women.

In summary, cervical gonorrhea infections can be missed by urine and self-collected vaginal swab samples. So some women test negative initially, until more accurate cervical samples are collected.

Oral and rectal infections

Other hard to detect sites of gonorrhea infection include the mouth and rectum.

  • Oral gonorrhea often causes no symptoms leading to delayed testing.
  • rectal infections also tend to be asymptomatic.
  • Urine and cervical samples miss these infections.
  • Symptoms like sore throat or anal discharge eventually prompt more accurate site-specific testing.

So oral and rectal gonorrhea infections explain some situations where initial urine or genital samples test negative. But more accurate testing of the mouth or rectum will eventually identify the infection.

Testing errors

Rarely, testing errors also explain negative test results in the presence of infection:

  • Human errors like mislabeling samples or mistaking results can lead to false negatives.
  • Lab errors in processing samples or reading tests also occur occasionally.
  • Equipment failures or expired reagents can affect test accuracy.

Though rare, it’s possible for simple human or technical errors in sample handling and processing to lead to incorrect test results.

Conclusion

In summary, there are several reasons why it’s possible to still have gonorrhea even if an initial test is negative:

  • False negatives, especially with urine tests
  • Asymptomatic infections going undetected
  • Testing during the post-treatment clearance window
  • Co-infections with chlamydia
  • Missed cervical, oral or rectal infections
  • Rare testing errors

If gonorrhea symptoms persist after a negative test, consider retesting with a more accurate sample type. Multiple body sites should be tested for complete STD screening. This minimizes the chance of missed infections.

Prompt retesting and treatment is important, as ongoing gonorrhea can have serious reproductive health consequences. Practicing safer sex by using condoms and getting regular screenings reduces the risk of asymptomatic gonorrhea transmission.

References

  1. Centers for Disease Control and Prevention. (2021). Gonorrhea – CDC Fact Sheet. Retrieved from https://www.cdc.gov/std/gonorrhea/stdfact-gonorrhea-detailed.htm
  2. Hwith, P. et al. (2018). Gonorrhoea: Diagnostic challenges and treatment options. Australian family physician, 47(11), 772-776.
  3. Dubbink, J.H. et al. (2016). False-negative and false-positive results in chlamydia trachomatis and Neisseria gonorrhoeae infections: a clinical audit in a sexually transmitted infection center in Amsterdam, the Netherlands. International journal of STD & AIDS, 27(13), 1224–1232.
  4. Papp, J.R. et al. (2014). Recommendations for the Laboratory-Based Detection of Chlamydia trachomatis and Neisseria gonorrhoeae — 2014. MMWR Recomm Rep, 63, 1-19.
  5. Unemo, M. et al. (2017). The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. Journal of antimicrobial chemotherapy, 72(6), 1796–1809.
  6. Allan-Blitz, L.T. et al. (2017). Cryptic gonorrhea and chlamydia infections in heterosexual men attending a sexually transmitted diseases clinic in Los Angeles: an evaluation of diagnostic approaches. Sexually transmitted diseases, 44(4), 223–228.
  7. Mlisana, K. et al. (2012). Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. The Journal of infectious diseases, 206(1), 6–14.
  8. Schachter J. et al. (2005). Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sexually transmitted diseases, 32(10), 637–642.
  9. Kent C. K. et al. (2005). Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41(1), 67–74.